Safety and Efficacy of Immunomodulator Drug Thalidomide in Multi-transfused Thalassemia Patients
Clinical trial NCT06888232 · COMPLETED
Trial details
- NCT number
- NCT06888232
- Sponsor
- Muhammad Aamir Latif
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-12-31
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.